/

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-003222-24-FR

Enrollment

Unknown

Registered

2012-09-26

Start date

2012-10-18

Completion date

Unknown

Last updated

2016-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: IXEL 50mg Pharmaceutical Form: Capsule Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: / Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 26 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 26

Exclusion criteria

Exclusion criteria: /

Design outcomes

Primary

Measure	Time frame
Main Objective: /;Secondary Objective: /;Primary end point(s): /;Timepoint(s) of evaluation of this end point: /	—

Secondary

Measure	Time frame
Secondary end point(s): /;Timepoint(s) of evaluation of this end point: /	—

Countries

France

Contacts

Public ContactLACARIN Patrick

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr0033473751195

Outcome results